Avatrapa impurity 12 manufacturers
|
| | Avatrapa impurity 12 Basic information | | Uses |
| Product Name: | Avatrapa impurity 12 | | Synonyms: | 5,6-Dichloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)nicotinamide;3-Pyridinecarboxamide, 5,6-dichloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-;Avatrombopag Impurity 14;5,6-dichloro-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]nicotinamide;Avatroposide impurities20;5,6-Dichloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)nicotinamide (Avatrombopag Impurity);Avatrapa impurity 14;Avatrapa impurity 12 | | CAS: | 570403-04-2 | | MF: | C23H24Cl3N5OS2 | | MW: | 556.96 | | EINECS: | | | Product Categories: | Intermediate;Intermediate | | Mol File: | 570403-04-2.mol |  |
| | Avatrapa impurity 12 Chemical Properties |
| density | 1.472±0.06 g/cm3(Predicted) | | pka | 4.03±0.70(Predicted) | | InChIKey | ZGOWFPLUBDKGAV-UHFFFAOYSA-N | | SMILES | C1=NC(Cl)=C(Cl)C=C1C(NC1=NC(C2SC=C(Cl)C=2)=C(N2CCN(C3CCCCC3)CC2)S1)=O |
| | Avatrapa impurity 12 Usage And Synthesis |
| Uses | 5,6-Dichloro-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazolin-2-yl]nicotinamide is an impurity of avatrombopag, a drug used to treat thrombocytopenia. |
| | Avatrapa impurity 12 Preparation Products And Raw materials |
|